{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:03:44Z","timestamp":1780049024572,"version":"3.53.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key Project of Science Popularization Research by the National Pharmaceutical Information Network of the Chinese Pharmaceutical Association","award":["CMEI2024KPYJ01007"],"award-info":[{"award-number":["CMEI2024KPYJ01007"]}]},{"name":"Key Project of Science Popularization Research by the National Pharmaceutical Information Network of the Chinese Pharmaceutical Association","award":["CMEI2024KPYJ00161"],"award-info":[{"award-number":["CMEI2024KPYJ00161"]}]},{"name":"The Tianshan Youth Talent Support Program of Xinjiang Uygur Autonomous Region, China","award":["2024TSYCQNTJ0039"],"award-info":[{"award-number":["2024TSYCQNTJ0039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s13318-026-00999-y","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T03:26:26Z","timestamp":1778383586000},"page":"269-280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants and Machine Learning Prediction of Subtherapeutic Sodium Valproate Concentrations in Epilepsy Management in Xinjiang, China"],"prefix":"10.1007","volume":"51","author":[{"given":"Hao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbar","family":"Kadeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,10]]},"reference":[{"issue":"11","key":"999_CR1","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1111\/epi.17058","volume":"62","author":"Y Lin","year":"2021","unstructured":"Lin Y, Hu S, Hao X, Duan L, Wang W, Zhou D, et\u00a0al. Epilepsy centers in China: current status and ways forward. Epilepsia. 2021;62(11):2640\u201350. https:\/\/doi.org\/10.1111\/epi.17058.","journal-title":"Epilepsia"},{"issue":"4","key":"999_CR2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S1474-4422(21)00023-5","volume":"20","author":"D Ding","year":"2021","unstructured":"Ding D, Zhou D, Sander JW, Wang W, Li S, Hong Z. Epilepsy in China: major progress in the past two decades. Lancet Neurol. 2021;20(4):316\u201326. https:\/\/doi.org\/10.1016\/S1474-4422(21)00023-5.","journal-title":"Lancet Neurol"},{"issue":"3","key":"999_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/CM9.0000000000002526","volume":"136","author":"W Liu","year":"2023","unstructured":"Liu W, Xu Y, Lin Y, Wang L, Zhou M, Yin P, et\u00a0al. Burden of epilepsy in China and its provinces, 1990 to 2019: findings from the global burden of disease study 2019. Chin Med J (Engl). 2023;136(3):305\u201312. https:\/\/doi.org\/10.1097\/CM9.0000000000002526.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"999_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/epi4.12554","volume":"7","author":"S Li","year":"2022","unstructured":"Li S, Wang Y, Wang W, Zhou D, Zhang H, Duan L, et\u00a0al. The National Comprehensive Governance for epilepsy prevention and control in China. Epilepsia Open. 2022;7(1):27\u201335. https:\/\/doi.org\/10.1002\/epi4.12554.","journal-title":"Epilepsia Open"},{"issue":"10","key":"999_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.tips.2009.07.002","volume":"30","author":"NN Nalivaeva","year":"2009","unstructured":"Nalivaeva NN, Belyaev ND, Turner AJ. Sodium valproate: an old drug with new roles. Trends Pharmacol Sci. 2009;30(10):509\u201314. https:\/\/doi.org\/10.1016\/j.tips.2009.07.002.","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"999_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s40262-022-01171-w","volume":"61","author":"K Lin","year":"2022","unstructured":"Lin K, Cao VFS, Au C, Dahri K. Clinical pharmacokinetic monitoring of free valproic acid levels: a systematic review. Clin Pharmacokinet. 2022;61(10):1345\u201363. https:\/\/doi.org\/10.1007\/s40262-022-01171-w.","journal-title":"Clin Pharmacokinet"},{"issue":"23","key":"999_CR7","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.12114\/j.issn.1007-9572.2023.0016","volume":"26","author":"J Ding","year":"2023","unstructured":"Ding J, Meng ZC, Zhang Y, Cui XH, Liu JR, He J, et\u00a0al. Retrospective analysis of 2992 times of therapeutic drug monitoring of valproic acid from 2019 to 2021 [J]. Chin Gen Pract. 2023;26(23):2923\u20139. https:\/\/doi.org\/10.12114\/j.issn.1007-9572.2023.0016.","journal-title":"Chin Gen Pract."},{"issue":"10","key":"999_CR8","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1111\/epi.18508","volume":"66","author":"C Johannessen Landmark","year":"2025","unstructured":"Johannessen Landmark C, Wolden M, S\u00e6tre J, Burns ML, Heger K, Kjeldsen SF, et\u00a0al. A precision approach to therapeutic drug monitoring of valproate to evaluate markers of toxicity. Epilepsia. 2025;66(10):3741\u201356. https:\/\/doi.org\/10.1111\/epi.18508.","journal-title":"Epilepsia"},{"issue":"4","key":"999_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/00498254.2022.2076632","volume":"52","author":"N Kaboudi","year":"2022","unstructured":"Kaboudi N, Alizadeh AA, Shayanfar A. Insilico models to predict tubular secretion or reabsorption clearance pathway using physicochemical properties and structural characteristics. Xenobiotica. 2022;52(4):346\u201352. https:\/\/doi.org\/10.1080\/00498254.2022.2076632.","journal-title":"Xenobiotica"},{"issue":"5","key":"999_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-025-09999-y","volume":"52","author":"N Kaboudi","year":"2025","unstructured":"Kaboudi N, Shekari T, Shayanfar A, Pimentel AS. Computational approaches for toxicology and pharmacokinetic properties prediction. J Pharmacokinet Pharmacodyn. 2025;52(5):51. https:\/\/doi.org\/10.1007\/s10928-025-09999-y.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"999_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s42492-025-00208-8","volume":"8","author":"K Slama","year":"2025","unstructured":"Slama K, Yahyaouy A, Riffi J, Mahraz MA, Tairi H. Comprehensive review of machine learning and deep learning techniques for epileptic seizure detection and prediction based on neuroimaging modalities. Vis Comput Ind Biomed Art. 2025;8(1):27. https:\/\/doi.org\/10.1186\/s42492-025-00208-8.","journal-title":"Vis Comput Ind Biomed Art"},{"issue":"1","key":"999_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/epi.18668","volume":"67","author":"MR Nazem-Zadeh","year":"2026","unstructured":"Nazem-Zadeh MR, Chang RS, Barnard S, Pardoe HR, Kuzniecky R, Mishra D, et\u00a0al. Development and validation of clinico-imaging machine learning and deep learning models to predict responses to initial antiseizure medications in epilepsy. Epilepsia. 2026;67(1):120\u201337. https:\/\/doi.org\/10.1111\/epi.18668.","journal-title":"Epilepsia"},{"issue":"10","key":"999_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70353","volume":"18","author":"TK Chung","year":"2025","unstructured":"Chung TK, Lee H. A comparison of AI and population PK models to predict the concentrations of antiepileptic drugs using therapeutic drug monitoring records. Clin Transl Sci. 2025;18(10):e70353. https:\/\/doi.org\/10.1111\/cts.70353.","journal-title":"Clin Transl Sci"},{"key":"999_CR14","doi-asserted-by":"publisher","DOI":"10.1055\/a-2593-3125","author":"J Xie","year":"2025","unstructured":"Xie J, Ma P, Pan X, Cao L, Liu R, Xiong L, et\u00a0al. Ensemble machine learning model for real-time valproic acid prediction in epilepsy treatment. Pharmacopsychiatry. 2025. https:\/\/doi.org\/10.1055\/a-2593-3125. (online ahead of print).","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"999_CR15","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00228-025-03874-y","volume":"81","author":"J Chen","year":"2025","unstructured":"Chen J, Wang J, Li K, Wu Y, Wang Z, Guo J, et\u00a0al. Dosing prediction of valproic acid in pediatric patients with epilepsy: population pharmacokinetic model or machine learning model? Eur J Clin Pharmacol. 2025;81(9):1333\u201341. https:\/\/doi.org\/10.1007\/s00228-025-03874-y.","journal-title":"Eur J Clin Pharmacol"},{"key":"999_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2022.106888","volume":"181","author":"J Wu","year":"2022","unstructured":"Wu J, Wang Y, Xiang L, Gu Y, Yan Y, Li L, et\u00a0al. Machine learning model to predict the efficacy of antiseizure medications in patients with familial genetic generalized epilepsy. Epilepsy Res. 2022;181:106888. https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.106888.","journal-title":"Epilepsy Res"},{"issue":"10","key":"999_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214315","volume":"105","author":"W Feng","year":"2025","unstructured":"Feng W, Nhu D, Anderson A, Thom D, Barnard SN, Zeibich R, et\u00a0al. Integrative deep learning of genomic and clinical data for predicting treatment response in newly diagnosed epilepsy. Neurology. 2025;105(10):e214315. https:\/\/doi.org\/10.1212\/WNL.0000000000214315.","journal-title":"Neurology"},{"key":"999_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2024.110212","volume":"163","author":"A Abdaltawab","year":"2025","unstructured":"Abdaltawab A, Chang LC, Mansour M, Koubeissi M. How accurate are machine learning models in predicting anti-seizure medication responses: a systematic review. Epilepsy Behav. 2025;163:110212. https:\/\/doi.org\/10.1016\/j.yebeh.2024.110212.","journal-title":"Epilepsy Behav"},{"issue":"1-2","key":"999_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0920-1211(02)00252-8","volume":"53","author":"S Dutta","year":"2003","unstructured":"Dutta S, Cloyd JC, Granneman GR, Collins SD. Oral\/intravenous maintenance dosing of valproate following intravenous loading: a simulation. Epilepsy Res. 2003;53(1\u20132):29\u201338. https:\/\/doi.org\/10.1016\/s0920-1211(02)00252-8.","journal-title":"Epilepsy Res"},{"issue":"5","key":"999_CR20","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/bcp.13510","volume":"84","author":"J Methaneethorn","year":"2018","unstructured":"Methaneethorn J. A systematic review of population pharmacokinetics of valproic acid. Br J Clin Pharmacol. 2018;84(5):816\u201334. https:\/\/doi.org\/10.1111\/bcp.13510.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"999_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.9740\/mhc.2017.01.013","volume":"7","author":"A VandenBerg","year":"2018","unstructured":"VandenBerg A, Broadway J, Lalich C, Kennedy R, Williams K. Valproate serum concentrations in patients with hypoalbuminemia and medical complications. Ment Health Clin. 2018;7(1):13\u20135. https:\/\/doi.org\/10.9740\/mhc.2017.01.013.","journal-title":"Ment Health Clin"},{"issue":"5","key":"999_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/JCP.0000000000001883","volume":"44","author":"C Trac","year":"2024","unstructured":"Trac C, Zecopoulos A, Ross C, Weeda E, McGraw D. Comparison of weight-based valproic acid dosing in treatment of mental illness among obese and nonobese patients. J Clin Psychopharmacol. 2024;44(5):468\u201371. https:\/\/doi.org\/10.1097\/JCP.0000000000001883.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"999_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0800","volume":"86","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Hao J, Wang P, Xu S, Zhou X, Wang J, et\u00a0al. Development and validation of a preoperative prediction model for neoplastic gallbladder polyps. Br J Hosp Med (Lond). 2025;86(2):1\u201315. https:\/\/doi.org\/10.12968\/hmed.2024.0800.","journal-title":"Br J Hosp Med (Lond)"},{"issue":"12","key":"999_CR24","doi-asserted-by":"publisher","first-page":"13031","DOI":"10.1002\/cam4.5977","volume":"12","author":"L Feng","year":"2023","unstructured":"Feng L, Shao L, Sun S, Zhang C, Cai B. Analysis of the efficacy and influencing factors of preoperative P-SOX neoadjuvant chemotherapy regimen for progressive gastric cancer-construction of a clinical prediction model. Cancer Med. 2023;12(12):13031\u201340. https:\/\/doi.org\/10.1002\/cam4.5977.","journal-title":"Cancer Med"},{"key":"999_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et\u00a0al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77. https:\/\/doi.org\/10.1186\/1471-2105-12-77.","journal-title":"BMC Bioinform"},{"issue":"1","key":"999_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3892\/mmr.2019.10841","volume":"21","author":"H Jiang","year":"2020","unstructured":"Jiang H, Gu J, Du J, Qi X, Qian C, Fei B. A 21\u2011gene support vector machine classifier and a 10\u2011gene risk score system constructed for patients with gastric cancer. Mol Med Rep. 2020;21(1):347\u201359. https:\/\/doi.org\/10.3892\/mmr.2019.10841.","journal-title":"Mol Med Rep"},{"issue":"9","key":"999_CR27","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1097\/JS9.0000000000002730","volume":"111","author":"N Shen","year":"2025","unstructured":"Shen N, Zhang Y, Ding Z, Li R, Quan X, Liu X, et\u00a0al. Predicting intraoperative blood loss risk in severe lumbar disc herniation patients undergoing PLIF: a multicenter cohort study using ensemble learning. Int J Surg. 2025;111(9):5904\u201313. https:\/\/doi.org\/10.1097\/JS9.0000000000002730.","journal-title":"Int J Surg"},{"key":"999_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jad.2025.02.063","volume":"377","author":"X Zhao","year":"2025","unstructured":"Zhao X, Wang Y, Li J, Liu W, Yang Y, Qiao Y, et\u00a0al. A machine-learning-derived online prediction model for depression risk in COPD patients: a retrospective cohort study from CHARLS. J Affect Disord. 2025;377:284\u201393. https:\/\/doi.org\/10.1016\/j.jad.2025.02.063.","journal-title":"J Affect Disord"},{"issue":"1","key":"999_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-00995-x","volume":"28","author":"Z Ye","year":"2023","unstructured":"Ye Z, An S, Gao Y, Xie E, Zhao X, Guo Z, et\u00a0al. The prediction of in-hospital mortality in chronic kidney disease patients with coronary artery disease using machine learning models. Eur J Med Res. 2023;28(1):33. https:\/\/doi.org\/10.1186\/s40001-023-00995-x.","journal-title":"Eur J Med Res"},{"issue":"9","key":"999_CR30","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s10815-024-03178-7","volume":"41","author":"TM Luong","year":"2024","unstructured":"Luong TM, Ho NT, Hwu YM, Lin SY, Ho JY, Wang RS, et\u00a0al. Beyond black-box models: explainable AI for embryo ploidy prediction and patient-centric consultation. J Assist Reprod Genet. 2024;41(9):2349\u201358. https:\/\/doi.org\/10.1007\/s10815-024-03178-7.","journal-title":"J Assist Reprod Genet"},{"issue":"12","key":"999_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cptl.2025.102460","volume":"17","author":"LN Bui","year":"2025","unstructured":"Bui LN, Ding Q. Logistic regression modeling: methodological insights and roadmap. Curr Pharm Teach Learn. 2025;17(12):102460. https:\/\/doi.org\/10.1016\/j.cptl.2025.102460.","journal-title":"Curr Pharm Teach Learn"},{"key":"999_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2025.111468","volume":"141","author":"X Cai","year":"2025","unstructured":"Cai X, Wen H, Ma J, Li X, Cheng G, Tian S, et\u00a0al. Genetic and clinical factors associated with the metabolism of valproic acid in post-neurosurgery patients. Prog Neuropsychopharmacol Biol Psychiatry. 2025;141:111468. https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111468.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"999_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s40263-015-0304-5","volume":"30","author":"AM Cook","year":"2016","unstructured":"Cook AM, Zafar MS, Mathias S, Stewart AM, Albuja AC, Bensalem-Owen M, et\u00a0al. Pharmacokinetics and clinical utility of valproic acid administered via continuous infusion. CNS Drugs. 2016;30(1):71\u20137. https:\/\/doi.org\/10.1007\/s40263-015-0304-5.","journal-title":"CNS Drugs"},{"issue":"2","key":"999_CR34","first-page":"537","volume":"33","author":"Y Wang","year":"2020","unstructured":"Wang Y, Hu W, Li Z. Influence of age and co-medication on the concentration and efficacy of valproic acid in Chinese epilepsy children. Pak J Pharm Sci. 2020;33(2):537\u201342.","journal-title":"Pak J Pharm Sci"},{"issue":"7","key":"999_CR35","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1055\/a-2357-8095","volume":"74","author":"N Idkaidek","year":"2024","unstructured":"Idkaidek N, Al-Tarawneh A, Alshoaibi L, Tuffaha H, Zinati A, Abdelqader M, et\u00a0al. Saliva versus plasma therapeutic drug monitoring of valproic acid in Jordanian patients. Drug Res (Stuttg). 2024;74(7):314\u201324. https:\/\/doi.org\/10.1055\/a-2357-8095.","journal-title":"Drug Res (Stuttg)"},{"issue":"7","key":"999_CR36","doi-asserted-by":"publisher","first-page":"782","DOI":"10.11817\/j.issn.1672-7347.2020.190360","volume":"45","author":"X Yang","year":"2020","unstructured":"Yang X, Wang P, Pan J, Wang C, Luo J, Ma H. Valproic acid concentration and biochemical indexes in epilepsy outpatients during monotherapy or combination therapy. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020;45(7):782\u20139. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2020.190360.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"999_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-26519-x","volume":"13","author":"Y Ohashi","year":"2023","unstructured":"Ohashi Y, Toyoda M, Saito N, Koizumi M, Kanai G, Komaba H, et\u00a0al. Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients. Sci Rep. 2023;13(1):93. https:\/\/doi.org\/10.1038\/s41598-022-26519-x.","journal-title":"Sci Rep"},{"issue":"1","key":"999_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-01953-z","volume":"21","author":"H Guan","year":"2020","unstructured":"Guan H, Zheng Y, Zhou X, Xu Y, Fu C, Xiao J, et\u00a0al. Efficacy of different urinary uric acid indicators in patients with chronic kidney disease. BMC Nephrol. 2020;21(1):290. https:\/\/doi.org\/10.1186\/s12882-020-01953-z.","journal-title":"BMC Nephrol"},{"issue":"1","key":"999_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11095-025-03817-3","volume":"42","author":"N Yao","year":"2025","unstructured":"Yao N, Zhao Q, Cao Y, Gu D, Zhang N. Prediction trough concentrations of valproic acid among Chinese adult patients with epilepsy using machine learning techniques. Pharm Res. 2025;42(1):79\u201391. https:\/\/doi.org\/10.1007\/s11095-025-03817-3.","journal-title":"Pharm Res"},{"issue":"10","key":"999_CR40","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s40262-024-01418-8","volume":"63","author":"E Karatza","year":"2024","unstructured":"Karatza E, Sinha J, Maglalang PD, Edginton A, Gonzalez D. Physiologically-based pharmacokinetic modeling of total and unbound valproic acid to evaluate dosing in children with and without hypoalbuminemia. Clin Pharmacokinet. 2024;63(10):1435\u201348. https:\/\/doi.org\/10.1007\/s40262-024-01418-8.","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"999_CR41","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1111\/bcp.14853","volume":"87","author":"A Madan","year":"2021","unstructured":"Madan A, Donovan PJ, Risetto T, Trenerry H, Lander CM. Monitoring for valproate and phenytoin toxicity in hypoalbuminaemia: a retrospective cohort study. Br J Clin Pharmacol. 2021;87(11):4341\u201353. https:\/\/doi.org\/10.1111\/bcp.14853.","journal-title":"Br J Clin Pharmacol"},{"key":"999_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/292683","volume":"2015","author":"D Zhang","year":"2015","unstructured":"Zhang D, Xiao J, Zhou N, Zheng M, Luo X, Jiang H, et\u00a0al. A genetic algorithm based support vector machine model for blood-brain barrier penetration prediction. BioMed Res Int. 2015;2015:292683. https:\/\/doi.org\/10.1155\/2015\/292683.","journal-title":"BioMed Res Int"},{"issue":"12","key":"999_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219636","volume":"14","author":"HT Abbas","year":"2019","unstructured":"Abbas HT, Alic L, Erraguntla M, Ji JX, Abdul-Ghani M, Abbasi QH, et\u00a0al. Predicting long-term type 2 diabetes with support vector machine using oral glucose tolerance test. PLoS ONE. 2019;14(12):e0219636. https:\/\/doi.org\/10.1371\/journal.pone.0219636.","journal-title":"PLoS ONE"},{"issue":"2","key":"999_CR44","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/bcpt.12776","volume":"121","author":"M Zhao","year":"2017","unstructured":"Zhao M, Zhang T, Li G, Qiu F, Sun Y, Zhao L. Associations of CYP2C9 and CYP2A6 polymorphisms with the concentrations of valproate and its hepatotoxin metabolites and valproate-induced hepatotoxicity. Basic Clin Pharmacol Toxicol. 2017;121(2):138\u201343. https:\/\/doi.org\/10.1111\/bcpt.12776.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"8","key":"999_CR45","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00228-020-02872-6","volume":"76","author":"HY Yoon","year":"2020","unstructured":"Yoon HY, Ahn MH, Yee J, Lee N, Han JM, Gwak HS. Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis. Eur J Clin Pharmacol. 2020;76(8):1053\u20138. https:\/\/doi.org\/10.1007\/s00228-020-02872-6.","journal-title":"Eur J Clin Pharmacol"},{"key":"999_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jpba.2014.04.009","volume":"97","author":"A Kotani","year":"2014","unstructured":"Kotani A, Kotani T, Ishii N, Hakamata H, Kusu F. The effect of hyperglycemia on the pharmacokinetics of valproic acid studied by high-performance liquid chromatography with electrochemical detection. J Pharm Biomed Anal. 2014;97:47\u201353. https:\/\/doi.org\/10.1016\/j.jpba.2014.04.009.","journal-title":"J Pharm Biomed Anal"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-026-00999-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-026-00999-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-026-00999-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:28:54Z","timestamp":1780046934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-026-00999-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["999"],"URL":"https:\/\/doi.org\/10.1007\/s13318-026-00999-y","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Key Project of Science Popularization Research by the National Pharmaceutical Information Network of the Chinese Pharmaceutical Association (project no.: CMEI2024KPYJ01007, CMEI2024KPYJ00161); the Tianshan Youth Talent Support Program of Xinjiang Uygur Autonomous Region, China (2024TSYCQNTJ0039).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Studies were performed in accordance with ethical principles based on the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards, International Council for Harmonisation Guideline for Good Clinical Practice, and applicable laws and regulations. This study has been approved by the Research Ethics Committee of the Sixth Affiliated Hospital of Xinjiang Medical University (approval no.: LFYLLSC20250730-001; date of approval: 30 July 2025).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All participants provided written informed consent.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Custom software or code used during the study are available from the corresponding author on reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Study design and article writing: Hao Yang. Blood drug level testing and data collection\/evaluation: Xue Lv. Data analysis: Lijuan Zhang. Participation in data collection and entry: AKBAR Kadeer. Article review: Xuelin Jiang. All authors have read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}